Monte Rosa Therapeutics Stock Performance
as on October 1, 2026 at 3:08 am IST
Day's Low
Day's High
$11.65$12.15
2.92%
Downside
1.25%
Upside
52 Week's Low
52 Week's High
$7.09$25.7740.92%
Downside
114.75%
Upside
Monte Rosa Therapeutics share price movements today
- Previous Close
- $11.74
- Open
- $11.72
- Volume
- 122.6K
- Market Cap
- $999.0M
- Day's Low - High
- $11.65 - $12.15
- 52 Week Low - High
- $7.09 - $25.77
Monte Rosa Therapeutics Historical Returns
- 1 Month Return
- -12.26 %
- 3 Month Return
- -51.49 %
- 1 Year Return
- + 58.43 %
- 3 Year Return
- + 145.09 %
- 5 Year Return
- -47.31 %
Monte Rosa Therapeutics Stock Fundamentals & Key Indicators
Check Monte Rosa Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$999.0M
EPS (TTM)
-2.18
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.37
Industry PE ratio
-8.70
PEG Ratio
0.65
EBITDA
-155.8M
Revenue (TTM)
28.7M
Profit Margin
92.94%
Return On Equity TTM
-43.31%
Monte Rosa Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Monte Rosa Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $999.0M | -47.31% | -5.37 | 92.94% | 0.00% | |
| StrongBuy | $43.2B | 643.29% | -22.77 | 0.00% | 0.00% | |
| Neutral | $78.8B | -47.13% | -24.72 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 24.01% | 17.96 | 84.86% | 0.49% |
Stock Returns calculator for Monte Rosa Therapeutics Stock including INR - Dollar returns
The Monte Rosa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Monte Rosa Therapeutics investment value today
Current value as on today
₹1,74,683
Returns
₹74,683
(+74.68%)
Returns from Monte Rosa Therapeutics Stock
₹61,943 (+61.94%)
Dollar Impact
₹12,740 (+12.74%)
Analyst Recommendation on Monte Rosa Therapeutics Stock
Based on 6 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Monte Rosa Therapeutics. Average target price of $28.5
Monte Rosa Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Monte Rosa Therapeutics.
What analysts predicted
57.89%UPSIDE
Target Price
$28.5
Current Price
$12
Analyzed by
6 Analysts
High
$37
Target
$28.50
Low
$25
Monte Rosa Therapeutics target price $28.5, a slight upside of 57.89% compared to current price of $12. According to 6 analysts rating.
Indian Investors' Interest in Monte Rosa Therapeutics Stock
Search interest for Monte Rosa Therapeutics Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Monte Rosa Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Monte Rosa Therapeutics Annual Profit & Loss
All numbers in Millions USD
Monte Rosa Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Monte Rosa Therapeutics Annual Cash Flow
All numbers in Millions USD
Monte Rosa Therapeutics News & Key Events
Today's Timeline - 08 September
Tue, 05:02 PM
-Monte Rosa announces Phase 2 trial of MRT-6160 for Sjögrens disease, triggering a $50 million milestone payment from Novartis.
Insights on Monte Rosa Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, GLUE has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 629.3%
NEGATIVE IMPACTPrice Dip
In the last 3 months, GLUE stock has moved down by -51.5%
About Monte Rosa Therapeutics
| Organisation | Monte Rosa Therapeutics |
| Headquarters | 321 Harrison Avenue, Boston, MA, 02118, US |
| Industry | Biotechnology |
| CEO | Markus Warmuth |
Key Management of Monte Rosa Therapeutics
Name | Title |
|---|---|
Ms. Jennifer Champoux | Chief Operating Officer |
Dr. Sharon Townson Ph.D. | Chief Scientific Officer |
Dr. Markus Warmuth M.D. | President, CEO & Director |
Mr. Filip Janku M.D., Ph.D. | Chief Medical Officer |
Mr. Magnus Walter DPHIL | Chief Technology Officer |
Dr. John C. Castle Ph.D. | Chief Data & Information Officer |
Mr. Andrew Funderburk | Chief Investor Relations and Strategy Officer |
Mr. Philip Nickson J.D., Ph.D. | Chief Business & Legal Officer |
Mr. Matthew Bowen | Corporate Controller & Principal Accounting Officer |
FAQs
What is Monte Rosa Therapeutics share price today?
Monte Rosa Therapeutics share price today is $12.00 as on . Monte Rosa Therapeutics share today touched a day high of $12.15 and a low of $11.65.
What is the 52 week high and 52 week low for Monte Rosa Therapeutics share?
Monte Rosa Therapeutics share touched a 52 week high of $25.77 on and a 52 week low of $7.09 on . Monte Rosa Therapeutics stock price today i.e. is trending at $12.00,which is 53.43% down from its 52 week high and 69.25% up from its 52 week low.
What is Monte Rosa Therapeutics's market capitalisation today?
Monte Rosa Therapeutics market capitalisation is $0.00T as on .
How to invest in Monte Rosa Therapeutics Stock (GLUE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Monte Rosa Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Monte Rosa Therapeutics Stock (GLUE) from India?
Indian investors can start investing in Monte Rosa Therapeutics (GLUE) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Monte Rosa Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Monte Rosa Therapeutics share’s latest price of $12.00 as on September 30, 2026 at 9:38 pm IST, you will get 0.8333 shares of Monte Rosa Therapeutics. Learn more about
fractional shares .
What are the returns that Monte Rosa Therapeutics has given to Indian investors in the last 5 years?
Monte Rosa Therapeutics stock has given -47.31% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?